A possible mechanism of impaired NK cytotoxicity in cancer patients: Down-regulation of DAP10 by TGF-β1

June Chul Lee, Kyung-Mi Lee, Yong Oon Ahn, Beomseok Suh, Dae Seog Heo

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Aims and background. Elevated TGF-β1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. However, the molecular mechanism of immunosuppression by TGF-β1 is not yet clarified. Methods. IL-2-activated human NK cells were cultured with TGF-β1. Protein levels of NKG2D and DAP10 were examined by FACS or immunoblot analyses. Real-time RTPCR was performed to quantify the transcription levels. MAPK inhibitors were used to investigate intracellular signaling. Results. TGF-β1 down-regulated total and surface NKG2D, which was partially dependent on transcriptional regulation. TGF-β1 treatment of human NK cells resulted in significant changes in both transcriptional and translational levels of DAP10. Moreover, treatment with bafilomycin A1 or folimycin restored total NKG2D levels in TGF-β1-treated NK cells. The impaired NKG2D down-modulation by TGF-β1 was not associated with activation of the MAPK signaling pathway. Conclusions. TGF-β1 down-modulates surface NKG2D expression by controlling the transcriptional and translational levels of DAP10.

Original languageEnglish
Pages (from-to)350-357
Number of pages8
JournalTumori
Volume97
Issue number3
Publication statusPublished - 2011 May 1

Fingerprint

Natural Killer Cells
Down-Regulation
Neoplasms
Immunosuppression
Interleukin-2
Therapeutics
Proteins
bafilomycin A1
concanamycin A

Keywords

  • DAP10
  • Human NK cells
  • NKG2D
  • TGF-β
  • Tumor immunity

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

A possible mechanism of impaired NK cytotoxicity in cancer patients : Down-regulation of DAP10 by TGF-β1. / Lee, June Chul; Lee, Kyung-Mi; Ahn, Yong Oon; Suh, Beomseok; Heo, Dae Seog.

In: Tumori, Vol. 97, No. 3, 01.05.2011, p. 350-357.

Research output: Contribution to journalArticle

Lee, June Chul ; Lee, Kyung-Mi ; Ahn, Yong Oon ; Suh, Beomseok ; Heo, Dae Seog. / A possible mechanism of impaired NK cytotoxicity in cancer patients : Down-regulation of DAP10 by TGF-β1. In: Tumori. 2011 ; Vol. 97, No. 3. pp. 350-357.
@article{35c6f1fbc7ad40db89b0e30b86b5e15e,
title = "A possible mechanism of impaired NK cytotoxicity in cancer patients: Down-regulation of DAP10 by TGF-β1",
abstract = "Aims and background. Elevated TGF-β1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. However, the molecular mechanism of immunosuppression by TGF-β1 is not yet clarified. Methods. IL-2-activated human NK cells were cultured with TGF-β1. Protein levels of NKG2D and DAP10 were examined by FACS or immunoblot analyses. Real-time RTPCR was performed to quantify the transcription levels. MAPK inhibitors were used to investigate intracellular signaling. Results. TGF-β1 down-regulated total and surface NKG2D, which was partially dependent on transcriptional regulation. TGF-β1 treatment of human NK cells resulted in significant changes in both transcriptional and translational levels of DAP10. Moreover, treatment with bafilomycin A1 or folimycin restored total NKG2D levels in TGF-β1-treated NK cells. The impaired NKG2D down-modulation by TGF-β1 was not associated with activation of the MAPK signaling pathway. Conclusions. TGF-β1 down-modulates surface NKG2D expression by controlling the transcriptional and translational levels of DAP10.",
keywords = "DAP10, Human NK cells, NKG2D, TGF-β, Tumor immunity",
author = "Lee, {June Chul} and Kyung-Mi Lee and Ahn, {Yong Oon} and Beomseok Suh and Heo, {Dae Seog}",
year = "2011",
month = "5",
day = "1",
language = "English",
volume = "97",
pages = "350--357",
journal = "Tumori",
issn = "0300-8916",
publisher = "Wichtig Publishing",
number = "3",

}

TY - JOUR

T1 - A possible mechanism of impaired NK cytotoxicity in cancer patients

T2 - Down-regulation of DAP10 by TGF-β1

AU - Lee, June Chul

AU - Lee, Kyung-Mi

AU - Ahn, Yong Oon

AU - Suh, Beomseok

AU - Heo, Dae Seog

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Aims and background. Elevated TGF-β1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. However, the molecular mechanism of immunosuppression by TGF-β1 is not yet clarified. Methods. IL-2-activated human NK cells were cultured with TGF-β1. Protein levels of NKG2D and DAP10 were examined by FACS or immunoblot analyses. Real-time RTPCR was performed to quantify the transcription levels. MAPK inhibitors were used to investigate intracellular signaling. Results. TGF-β1 down-regulated total and surface NKG2D, which was partially dependent on transcriptional regulation. TGF-β1 treatment of human NK cells resulted in significant changes in both transcriptional and translational levels of DAP10. Moreover, treatment with bafilomycin A1 or folimycin restored total NKG2D levels in TGF-β1-treated NK cells. The impaired NKG2D down-modulation by TGF-β1 was not associated with activation of the MAPK signaling pathway. Conclusions. TGF-β1 down-modulates surface NKG2D expression by controlling the transcriptional and translational levels of DAP10.

AB - Aims and background. Elevated TGF-β1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. However, the molecular mechanism of immunosuppression by TGF-β1 is not yet clarified. Methods. IL-2-activated human NK cells were cultured with TGF-β1. Protein levels of NKG2D and DAP10 were examined by FACS or immunoblot analyses. Real-time RTPCR was performed to quantify the transcription levels. MAPK inhibitors were used to investigate intracellular signaling. Results. TGF-β1 down-regulated total and surface NKG2D, which was partially dependent on transcriptional regulation. TGF-β1 treatment of human NK cells resulted in significant changes in both transcriptional and translational levels of DAP10. Moreover, treatment with bafilomycin A1 or folimycin restored total NKG2D levels in TGF-β1-treated NK cells. The impaired NKG2D down-modulation by TGF-β1 was not associated with activation of the MAPK signaling pathway. Conclusions. TGF-β1 down-modulates surface NKG2D expression by controlling the transcriptional and translational levels of DAP10.

KW - DAP10

KW - Human NK cells

KW - NKG2D

KW - TGF-β

KW - Tumor immunity

UR - http://www.scopus.com/inward/record.url?scp=79960849046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960849046&partnerID=8YFLogxK

M3 - Article

C2 - 21789015

AN - SCOPUS:79960849046

VL - 97

SP - 350

EP - 357

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 3

ER -